Literature DB >> 8816810

Relationship between psychostimulant-induced "high" and dopamine transporter occupancy.

N D Volkow1, G J Wang, J S Fowler, S J Gatley, Y S Ding, J Logan, S L Dewey, R Hitzemann, J Lieberman.   

Abstract

The ability of cocaine to inhibit the dopamine transporter (DAT) appears to be crucial for its reinforcing properties. The potential use of drugs that produce long-lasting inhibition of the DAT as a mean of preventing the "high" and reducing drug-seeking behavior has become a major strategy in medication development. However, neither the relation between the high and DAT inhibition nor the ability to block the high by prior DAT blockade have ever been demonstrated. To evaluate if DAT could prevent the high induced by methylphenidate (MP), a drug which like cocaine inhibits the DAT, we compared the responses in eight non-drug-abusing subjects between the first and the second of two MP doses (0.375 mg/kg, i.v.) given 60 min apart. At 60 min the high from MP has returned to baseline, but 75-80% of the drug remains in brain. Positron-emission tomography and [11C]d-threo-MP were used to estimate DAT occupancies at different times after MP. DAT inhibition by MP did not block or attenuate the high from a second dose of MP given 60 min later, despite a 80% residual transporter occupancy from the first dose. Furthermore some subjects did not perceive a high after single or repeated administration despite significant DAT blockade. These results indicate that DAT occupancy is not sufficient to account for the high, and that for DAT inhibitors to be therapeutically effective, occupancies > 80% may be required.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816810      PMCID: PMC38394          DOI: 10.1073/pnas.93.19.10388

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

Review 1.  The pharmacology of cocaine related to its abuse.

Authors:  C E Johanson; M W Fischman
Journal:  Pharmacol Rev       Date:  1989-03       Impact factor: 25.468

2.  A choice procedure for drug reinforcers: cocaine and methylphenidate in the rhesus monkey.

Authors:  C E Johanson; C R Schuster
Journal:  J Pharmacol Exp Ther       Date:  1975-05       Impact factor: 4.030

3.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

Authors:  M C Ritz; R J Lamb; S R Goldberg; M J Kuhar
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

4.  Reinforcing and subjective effects of several anorectics in normal human volunteers.

Authors:  L D Chait; E H Uhlenhuth; C E Johanson
Journal:  J Pharmacol Exp Ther       Date:  1987-09       Impact factor: 4.030

5.  A new PET ligand for the dopamine transporter: studies in the human brain.

Authors:  N D Volkow; Y S Ding; J S Fowler; G J Wang; J Logan; S J Gatley; D J Schlyer; N Pappas
Journal:  J Nucl Med       Date:  1995-12       Impact factor: 10.057

6.  Mazindol treatment for cocaine dependence.

Authors:  S M Stine; J H Krystal; T R Kosten; D S Charney
Journal:  Drug Alcohol Depend       Date:  1995-10       Impact factor: 4.492

7.  Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report.

Authors:  F Gawin; C Riordan; H Kleber
Journal:  Am J Drug Alcohol Abuse       Date:  1985       Impact factor: 3.829

8.  Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen.

Authors:  B K Madras; M A Fahey; J Bergman; D R Canfield; R D Spealman
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

9.  Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.

Authors:  J Bergman; B K Madras; S E Johnson; R D Spealman
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

10.  Neuroleptic reduction of cocaine-induced paranoia but not euphoria?

Authors:  F H Gawin
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

View more
  43 in total

1.  Imaging the functioning human brain.

Authors:  X Weng; Y S Ding; N D Volkow
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 2.  Neuroimaging in drug abuse.

Authors:  Kimberly P Lindsey; S John Gatley; Nora D Volkow
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

3.  Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs.

Authors:  B E H Sumner; L A Cruise; D A Slattery; D R Hill; M Shahid; B Henry
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

Review 4.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

Review 5.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

6.  The dopamine antagonist cis-flupenthixol blocks the expression of the conditioned positive but not the negative effects of cocaine in rats.

Authors:  Jennifer M Wenzel; Zu-In Su; Kerisa Shelton; Hiram M Dominguez; Victoria A von Furstenberg; Aaron Ettenberg
Journal:  Pharmacol Biochem Behav       Date:  2013-09-05       Impact factor: 3.533

7.  A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study.

Authors:  C J Spellicy; M J Harding; S C Hamon; J J Mahoney; J A Reyes; T R Kosten; T F Newton; R De La Garza; D A Nielsen
Journal:  Genes Brain Behav       Date:  2014-03-17       Impact factor: 3.449

Review 8.  Tactics for preclinical validation of receptor-binding radiotracers.

Authors:  Susan Z Lever; Kuo-Hsien Fan; John R Lever
Journal:  Nucl Med Biol       Date:  2016-09-03       Impact factor: 2.408

Review 9.  Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants?

Authors:  Scott Mackey; Martin Paulus
Journal:  Neurosci Biobehav Rev       Date:  2012-12-17       Impact factor: 8.989

10.  Methamphetamine Cured my Cocaine Addiction.

Authors:  Colin N Haile; Richard De La Garza; Thomas F Newton
Journal:  J Addict Res Ther       Date:  2010-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.